Cargando…
SPOP targets the immune transcription factor IRF1 for proteasomal degradation
Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription f...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491434/ https://www.ncbi.nlm.nih.gov/pubmed/37622993 http://dx.doi.org/10.7554/eLife.89951 |
_version_ | 1785104057252184064 |
---|---|
author | Schwartz, Irene Vunjak, Milica Budroni, Valentina Cantoran García, Adriana Mastrovito, Marialaura Soderholm, Adrian Hinterndorfer, Matthias de Almeida, Melanie Hacker, Kathrin Wang, Jingkui Froussios, Kimon Jude, Julian Decker, Thomas Zuber, Johannes Versteeg, Gijs A |
author_facet | Schwartz, Irene Vunjak, Milica Budroni, Valentina Cantoran García, Adriana Mastrovito, Marialaura Soderholm, Adrian Hinterndorfer, Matthias de Almeida, Melanie Hacker, Kathrin Wang, Jingkui Froussios, Kimon Jude, Julian Decker, Thomas Zuber, Johannes Versteeg, Gijs A |
author_sort | Schwartz, Irene |
collection | PubMed |
description | Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a ‘Goldilocks’ zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance. |
format | Online Article Text |
id | pubmed-10491434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-104914342023-09-09 SPOP targets the immune transcription factor IRF1 for proteasomal degradation Schwartz, Irene Vunjak, Milica Budroni, Valentina Cantoran García, Adriana Mastrovito, Marialaura Soderholm, Adrian Hinterndorfer, Matthias de Almeida, Melanie Hacker, Kathrin Wang, Jingkui Froussios, Kimon Jude, Julian Decker, Thomas Zuber, Johannes Versteeg, Gijs A eLife Immunology and Inflammation Adaptation of the functional proteome is essential to counter pathogens during infection, yet precisely timed degradation of these response proteins after pathogen clearance is likewise key to preventing autoimmunity. Interferon regulatory factor 1 (IRF1) plays an essential role as a transcription factor in driving the expression of immune response genes during infection. The striking difference in functional output with other IRFs is that IRF1 also drives the expression of various cell cycle inhibiting factors, making it an important tumor suppressor. Thus, it is critical to regulate the abundance of IRF1 to achieve a ‘Goldilocks’ zone in which there is sufficient IRF1 to prevent tumorigenesis, yet not too much which could drive excessive immune activation. Using genetic screening, we identified the E3 ligase receptor speckle type BTB/POZ protein (SPOP) to mediate IRF1 proteasomal turnover in human and mouse cells. We identified S/T-rich degrons in IRF1 required for its SPOP MATH domain-dependent turnover. In the absence of SPOP, elevated IRF1 protein levels functionally increased IRF1-dependent cellular responses, underpinning the biological significance of SPOP in curtailing IRF1 protein abundance. eLife Sciences Publications, Ltd 2023-08-25 /pmc/articles/PMC10491434/ /pubmed/37622993 http://dx.doi.org/10.7554/eLife.89951 Text en © 2023, Schwartz, Vunjak, Budroni et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Immunology and Inflammation Schwartz, Irene Vunjak, Milica Budroni, Valentina Cantoran García, Adriana Mastrovito, Marialaura Soderholm, Adrian Hinterndorfer, Matthias de Almeida, Melanie Hacker, Kathrin Wang, Jingkui Froussios, Kimon Jude, Julian Decker, Thomas Zuber, Johannes Versteeg, Gijs A SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title | SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title_full | SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title_fullStr | SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title_full_unstemmed | SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title_short | SPOP targets the immune transcription factor IRF1 for proteasomal degradation |
title_sort | spop targets the immune transcription factor irf1 for proteasomal degradation |
topic | Immunology and Inflammation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491434/ https://www.ncbi.nlm.nih.gov/pubmed/37622993 http://dx.doi.org/10.7554/eLife.89951 |
work_keys_str_mv | AT schwartzirene spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT vunjakmilica spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT budronivalentina spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT cantorangarciaadriana spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT mastrovitomarialaura spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT soderholmadrian spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT hinterndorfermatthias spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT dealmeidamelanie spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT hackerkathrin spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT wangjingkui spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT froussioskimon spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT judejulian spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT deckerthomas spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT zuberjohannes spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation AT versteeggijsa spoptargetstheimmunetranscriptionfactorirf1forproteasomaldegradation |